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Abstract  27 
Multiple classes of environmental contaminants have been found in aquatic 28 
environments, globally. Understanding internalised concentrations in the organism 29 
could further improve the risk assessment process. The present study is concerned 30 
with the determination of several contaminant classes (107 compounds) in Gammarus 31 
pulex collected from 15 sites covering 5 river catchments across Suffolk, UK. 32 
Quantitative method performance was acceptable for 67 compounds including 33 
pharmaceuticals, pesticides, illicit drugs and drugs of abuse. A total of 56 compounds 34 
were detectable and ranged from <LOQ to 45.3 ng g-1, with cocaine and lidocaine 35 
being the most frequently detected compounds present in all biota samples (n=66). 36 
For surface water, 50 compounds were detectable and ranged from <LOQ to 382.2 37 
ng L-1. Additionally, some pesticides currently not approved for use were detected, 38 
including fenuron that reached a maximum of 16.1 ng g-1. The internal concentrations 39 
of pesticides were used to estimate toxic pressure which showed that for the measured 40 
pesticides toxic pressure was low ranging from logTU ≤-7 to ≤-2. This methodology 41 
was extended to pharmaceuticals and drugs of abuse in a novel approach that 42 
proposed the use of pharmacological data (human therapeutic plasma concentrations) 43 
to estimate the likelihood of an effect (or effect pressure) to occur based on the internal 44 
exposure of the organism. The quantified effect pressure ranged from logEU ≤-9 to ≤1 45 
with haloperidol showing the largest likelihood for an effect. The approach showed that 46 
several pharmaceuticals have the potential to elicit effects but further investigation 47 
surrounding thresholds for effects would be required. This new approach presented 48 
showed potential to be used to improve risk assessment for pharmaceuticals in the 49 
environment.  50 
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1. Introduction 53 
The contamination of the aquatic environment has been the focus of many 54 
investigations and many issues have been identified with respect to a number of 55 
classes of compounds including pharmaceuticals [1] and plant protection products 56 
(pesticides) [2] Within each class, adverse effects of some specific contaminants on 57 
biota have been well studied, although effects and/or associated risks are often 58 
derived based on exposure concentration levels measured external to the organism 59 
(e.g., in water or sediment). A reason for this is that the determination of trace 60 
contaminants in biota has traditionally been very challenging, not only in terms of the 61 
analytical selectivity required to reliably separate hundreds of different compounds but 62 
to do so quantitatively at trace concentrations (e.g. pg-ng g-1) [1]. However, advances 63 
in analytical workflows have now enabled trace quantitative measurements in complex 64 
biological matrices such that internalised contaminant concentrations can be used to 65 
set thresholds for effects [3-5].  66 
Arguably, routine determination of internalised concentrations of 67 
pharmaceuticals in particular is still critically lacking [1]. This is also true for some other 68 
contaminant classes such as illicit drugs. Additionally, neonicotinoid insecticides, 69 
which are largely used on land and have rarely been targeted for measurement in 70 
aquatic fauna except for a small number of recent studies in fish and invertebrates [6-71 
8]. However, other pesticides have been more routinely monitored in aquatic biota, 72 
such as organochlorine insecticides, which are reported at the low to mid ng g-1 range 73 
in both vertebrates and invertebrates [9, 10]. This is likely due to extensive regulation 74 
of these types of contaminants following seminal research in the 1950s (e.g., with 75 
dichlorodiphenyltrichloroethane (DDT) [11]) to the more recent Stockholm Convention 76 
treaty on persistent organic pollutants which cover many other such compounds [12].  77 
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Previous studies have used the Species at Risk (SPEAR) index [13, 14] to 78 
relate the ‘toxic pressure’ of pesticides in agricultural catchments to the impact on 79 
invertebrate communities and is quantified in toxic units (TU) [15]. The TU is derived 80 
from the ratio between the measured concentration of the contaminant in surface 81 
water and known toxicity data, such as the LC50. Recently, the TU approach has been 82 
applied using internal pesticide concentration measurements and predicted EC50 83 
values [6]. Aside from pesticides, this approach could also be extended for other 84 
contaminant types such as pharmaceuticals. This would prove particularly useful as it 85 
would provide an estimate of risk, based on both measured concentrations and effect 86 
data. This has already been performed for selected pharmaceuticals in the Antarctic 87 
peninsula [16]. However, a significant barrier to wider application is that there is a 88 
paucity of effect data for pharmaceuticals and reported EC50 data can vary 89 
considerably [17]. Other approaches such as the use of critical environmental 90 
concentrations (CECs) proposed by Fick et al. [18], which are based on the fish plasma 91 
model [19], could be a useful alternative to the use ecotoxicity endpoint data.  92 
The aim of this work was to determine the extent of contaminant occurrence 93 
and to estimate the toxic pressure of pesticides and extend this approach to 94 
pharmaceuticals, drugs of abuse and illicit drugs to determine an ‘effect pressure’ 95 
across several watercourses in Suffolk. This was achieved through the development 96 
of an extended analytical methodology to reliably quantify several classes of 97 
contaminants in both surface waters and a freshwater invertebrate species 98 
(Gammarus pulex). Samples were collected from 15 sites covering five river 99 
catchments and used to estimate toxic/effect pressure. Internalised concentrations 100 
determined herein and a previously developed model for prediction of bioconcentration 101 
factors in G. pulex [20] along with the well-established EPISuite [21] BCF predictions 102 
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in fish were used to calculate internal toxic units (TUint) and effect units (EUint) for 103 
pesticides and pharmaceuticals, respectively.   104 
 105 
2. Materials and Methods 106 
2.1 Reagents, chemicals and consumables 107 
HPLC grade methanol, acetonitrile, and LC-MS grade (Optima™) ammonium acetate 108 
were purchased from Fischer Scientific (Loughborough, UK). A total of 141 109 
compounds were used in this study (see Supplementary Information (SI)). Of these, 110 
85 were pharmaceuticals/illicits, 22 were pesticides and 34 were stable isotopically 111 
labelled internal standards (SIL-IS). All analytical standards were of a purity of ≥ 97%. 112 
Ultra-pure water was obtained from a Millipore Milli-Q water purification system with a 113 
specific resistance of 18.2 MΩ cm or greater (Millipore, Bedford, MA, USA). Stock 114 
solutions (1 mg mL-1) were prepared in methanol or acetonitrile and stored in silanised 115 
amber vials (20 mL). Working solutions were prepared daily in ultra-pure water, as 116 
required. All solutions were stored at -20 °C and in the dark to reduce possible 117 
degradation. 118 
 119 
2.2 Sample collection  120 
Samples were collected in July 2018. Locations were chosen based on previous 121 
Environment Agency sampling sites in catchments of the river Alde, Waveney, Stour, 122 
Gipping and Deben (Figure 1). Macroinvertebrates were collected by kick sampling 123 
into a 250 µm net. G. pulex was present at all sites except the River Box in the Stour 124 
catchment and one site on the River Waveney, where the most abundant 125 
macroinvertebrate Ephemera vulgata (larvae) and Asellus aquaticus was sampled 126 
instead. At the site on the river Gipping, G.pulex numbers were low and the caddis fly 127 
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Hydropyshe pellucidula (larvae) were also sampled. Macroinvertebrates were sorted 128 
on site, excess water removed by tissue paper and immediately frozen on dry ice. 129 
Samples were kept at -80 oC prior to processing. Water pH and temperature were 130 
measured (Table S3) and a 500 mL water sample taken, acidified (0.1% HCl) and 131 
stored at 4 oC for a maximum of 4 days prior to analysis to improve stability of analytes 132 
as shown in previous studies [22, 23].  133 
 134 
2.3 Sample preparation  135 
Prior to extraction, frozen G. pulex samples were lyophilised at -50 °C under vacuum 136 
for 24 h. Pooled samples of 5-6 organisms were placed into 2 mL Eppendorf tubes 137 
with a 3 mm diameter tungsten carbide bead and subsequently ground into a fine 138 
powder using a TissueLyser LT (Qiagen, Hilden, Germany) set at 50 Hz for 5 min. 139 
Freeze-dried composite samples of G. pulex material (20 mg) were transferred to a 140 
new 2 mL Eppendorf tube with any necessary spiking of standards or SIL-IS carried 141 
out directly onto the solid matrix using a 100 μL volume of an appropriate working 142 
solution before proceeding with the extraction. A 2 mL volume of 3:1 (MeCN:H2O) 143 
acidified with 0.1% (v/v) glacial acetic acid was added to the material and agitated for 144 
5 min at 50 Hz in the Tissuelyser LT. The samples were then placed in an ultrasonic 145 
bath for 15 min followed by centrifugation for 5 min at 14,000 rpm to pellet insoluble 146 
particulate matter. Following extraction and settling, an aliquot of the supernatant (1.9 147 
mL) was diluted to 100 mL with 10 mM ammonium acetate in ultra-pure water (pH 148 
6.5). Tandem solid phase extraction (SPE) was then carried out on the diluted sample 149 
using a Strata Alumina-N cartridge (6 mL, 1 g, Phenomenex Ltd., Cheshire, UK) 150 
coupled to an Oasis HLB cartridge (6 mL, 200 mg, Waters Corp., Hertfordshire, UK). 151 
Tandem SPE was utilised to remove interfering pigments and lipids (alumina) and pre-152 
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concentrate target analytes (HLB). Before loading of the sample, the combined SPE 153 
cartridges were first conditioned with 6 mL of methanol and 6 mL of ultra-pure water 154 
with 10 mM ammonium acetate. After sample loading, both cartridges were then 155 
washed with 1 mL ultra-pure water and dried for ~30 min under vacuum. Cartridges 156 
were then stored at -20 °C until analysis. Cartridges were eluted with 5 mL MeOH and 157 
dried under pure nitrogen (1.0 bar) at 35 °C using a TurboVap LV (Biotage, Uppsala, 158 
Sweden). Extract residues were reconstituted in 0.1 mL 90:10 (v/v) 10 mM ammonium 159 
acetate in H2O:MeCN (optimised). Surface water samples were filtered through a 0.45 160 
µm glass-fibre filter and split into three aliquots (100 mL). Surface water samples then 161 
underwent SPE and reconstitution as described above, but without use of the Strata 162 
Alumina-N cartridges (as pigments were not problematic). Any necessary spiking or 163 
liquid volume measurements were carried out using positive displacement pipettes 164 
(Gilson Microman, Villiers-le-Bel, France). 165 
 166 
2.4 Instrumental analysis and conditions 167 
Briefly, liquid chromatography (LC) was performed on a Vanquish series LC system 168 
(ThermoFisher Scientific, Hemel Hempstead, UK) using a Waters SunFire C18 column 169 
(3.5 μm, 2.1 mm × 150 mm, Waters Corp., Milford, MA, USA) with a KrudKatcher™ 170 
Ultra pre-filter (0.1 mm ID, 0.5 μm filter, Phenomenex, Macclesfield, UK) and a Sunfire 171 
C18 VanGuard Cartridge (3.5 μm, 2.1 mm x 5 mm) at a flow rate of 0.3 mL min-1 and 172 
an injection volume of 20 μL. Mobile phases were 90:10 (v/v) 10 mM ammonium 173 
acetate in H2O:MeCN (A) and 20:80 (v/v) 10 mM ammonium acetate in H2O:MeCN 174 
(B). The gradient elution profile followed a linear ramp of mobile phase B which 175 
increased to 10 % at 1 min, 35 % at 5.6 min, 40 % at 7 min, 50 % at 8 min and 100 % 176 
at 11 min and was held for a further 11 min before returning to initial conditions. Re-177 
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equilibration time was 3 min resulting in an overall run time of 25 min. Detection and 178 
quantification was carried out with a TSQ Vantage triple quadrupole mass 179 
spectrometer (Thermo Fisher Scientific, Hemel Hempstead, UK) equipped with an 180 
atmospheric pressure interface–heated electrospray ionisation (API-HESI-II) source. 181 
Mass spectrometry (MS) was performed in selected reaction monitoring (SRM) mode 182 
using positive–negative ionisation polarity switching. See the SI for full details of 183 
analytical conditions and method performance testing procedures.  184 
 185 
2.6 Estimation of toxic and effect pressure 186 
Toxic pressure was calculated according to Munz et al. [6] using toxic units (TU) to 187 
estimate the internal toxic pressure of pesticides. The internal toxic unit (TUint) or effect 188 
unit (EUint) used here is defined by equations 1-3. 189 
 190 
𝐸𝐶50𝑖𝑛𝑡 = 𝐸𝐶50 × 𝐵𝐶𝐹 (1) 191 
𝑇𝑈𝑖𝑛𝑡 =  
𝐶𝑖
𝐸𝐶50𝑖𝑛𝑡
 (2) 192 
𝐸𝑈𝑖𝑛𝑡 =  
𝐶𝑖
𝐶𝐸𝐶
   (3) 193 
Where, EC50int is the internal concentration which affects 50% of the population; EC50 194 
is the exposure medium concentration affecting 50% of the population; BCF is the 195 
bioconcentration factor; Ci is the concentration of contaminant determined in the 196 
organism. For pesticides, available EC50 values (48 h acute in Daphnia magna) 197 
available from the Pesticide Properties Database [24]. The BCFs were estimated from 198 
both EPI Suite BCFBAF v3.02 [21] software and our own previously developed 199 
artificial neural network (ANN) for prediction of BCFs in G. pulex [20] (Figure 2). The 200 
comparison of the predicted BCFs between both approaches showed relatively good 201 
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agreement for most cases (see Table S4 and Figure S1) and overall were not 202 
statistically significant (p-value = 0.36).  203 
For pharmaceuticals, drugs of abuse and illicit drugs, EC50 values were substituted 204 
(due to lack of available data) with CECs [18]. Here, the CEC is the estimated surface 205 
water concentration that will give rise to a fish plasma concentration equivalent to the 206 
human therapeutic plasma concentration (Equation 4). Thus, it would be expected and 207 
assumed that if drug targets are conserved, an effect would be elicited.  208 
𝐶𝐸𝐶 =  
𝐻𝑇𝑃𝐶
(𝐶𝑅 × 𝑃𝑏𝑙𝑜𝑜𝑑:𝑤𝑎𝑡𝑒𝑟)
   (4)  209 
Where, HTPC is the human therapeutic plasma concentration (µg mL-1), CR is the 210 
concentration ratio between the human therapeutic plasma concentration and the fish 211 
steady-state plasma concentration (assumed to be 1 herein), Pblood:water is the partition 212 
coefficient of a compound between blood and water.  213 
 214 
3. Results and Discussion 215 
3.1 Method performance 216 
Method performance was assessed in G. pulex to ensure that the method could 217 
reliably quantify targeted analytes at the low ng g-1 concentration level (Table 1). A 218 
total of 107 compounds were assessed and 67 compounds (55 pharmaceuticals and 219 
12 pesticides) were deemed acceptable for quantification purposes with the remaining 220 
analytes suitable for qualitative analysis (according to ICH guidelines). A t-test 221 
assuming unequal variances showed that there was no significant difference between 222 
the performance of the method for either pharmaceuticals or pesticides in terms of 223 
recovery and precision (p > 0.05). The method showed good sensitivity for trace-224 
analysis with LOQs ranging from 0.09 – 25.2 ng g-1 (median: 1.7 ng g-1) dry weight 225 
and LODs as low as 0.03 ng g-1 (median: 0.6 ng g-1) dry weight. The sensitivity of the 226 
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method was comparable to others that have determined pharmaceuticals and 227 
pesticides in invertebrates. For example, Inostroza et al., had method quantification 228 
limits (MQLs) of 0.01-2.13 ng g-1 wet weight [4], Althakafy et al., reported detection 229 
limits ranging 0.04 – 2.38 ng g-1 wet weight [25] and Munz et al., achieved LOQs of 230 
0.1 to 9 ng g-1 wet weight [6]. Linearity was acceptable (R2 >0.98) and the 231 
chromatographic separation showed good reproducibility with an average standard 232 
deviation in retention time of ±0.015 min (n = 5). The repeatability of the method was 233 
also acceptable with average intra-day imprecision of 9±5%, 9±4% and 8±4% at three 234 
different concentrations of 25, 50 and 100 ng g-1 dry weight. Inter-day precision 235 
determined at 50 ng g-1 across three days showed slightly lower precision but was still 236 
considered acceptable (average 14±4%) and was perhaps due to the inhomogeneity 237 
of such small samples and different operators between days. Absolute recoveries of 238 
the method ranged from 26 – 100 % (average: 74 %)  and is in line with a recent study 239 
that focussed on quantification of both pharmaceuticals and pesticides in G. pulex 240 
where recovery ranged from 9 – 70% [6]. Method accuracy averaged 92 ±10 %, 97 241 
±12 % and 104 ±9 % compared to the expected nominal concentration at 25, 50 and 242 
100 ng g-1.  243 
 244 
3.2 Biomonitoring of emerging contaminants across Suffolk catchments  245 
Occurrence studies are often focussed on the determination of contaminant 246 
concentrations in surface water samples and other abiotic matrices such as 247 
wastewater and sediment. The limitation of this is approach is that for spot sampling 248 
of water, for example, temporal and spatial fluctuations can be considerable and are 249 
unlikely to be representative of a chronic exposure scenario. Alternatively, passive 250 
sampling that represents a time-weighted average concentration is generally 251 
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considered semi-quantitative [26]. Furthermore, these measurements do not 252 
accurately represent the real risk to aquatic wildlife as they do not account for 253 
bioavailability and it is the internalised xenobiotic concentration that will be the initiating 254 
event for any adverse effects. As such, biomonitoring campaigns are now receiving 255 
more attention for their importance in determining exposure and hazard [6, 27].  256 
Both water and biota samples were collected across 15 sites in the county of 257 
Suffolk. The 15 sites covered 5 different river catchments including Gipping, Alde, 258 
Deben, Stour and Waveney. Across the 67 compounds determined, concentrations of 259 
compounds were generally very low in both biota samples (parts per billion range) and 260 
water samples (parts per trillion range). For biota samples (n = 66), the average 261 
concentration determined was 4.3 ±5.2 ng g-1, with maximum and minimum 262 
concentrations of 45.5 ng g-1 (propranolol) and 0.2 ng g-1 (acetamiprid), respectively 263 
(Figure 3). In comparison to surface water samples, concentrations averaged 23.8 264 
±54.9 ng L-1, with the maximum and minimum concentrations of 382.2 ng L-1 (tramadol) 265 
and 0.1 ng L-1 (nordiazepam), respectively (Figure 4). In general, Site 1 in the Deben 266 
catchment showed increased concentrations of compounds such as ketamine, 267 
carbamazepine and citalopram compared to the other sites within the same catchment 268 
and between the remaining catchments. These higher concentrations also coincide 269 
with higher concentrations in surface water for compounds such as ketamine, 270 
carbamazepine and tramadol, the source of which is unclear but for these compounds 271 
their removal at WWTPs is low [28]. Debenham is a large village of 2200 inhabitants 272 
(Figure 1) served by a small WWTP upstream of the sample site. The sources for 273 
these contaminants are likely to be related to public consumption and output through 274 
WWTP effluents (for pharmaceuticals, drugs of abuse and illicits). A previous study 275 
that has quantified related compounds in influent and effluent samples from a WWTP 276 
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in London showed that the concentrations in the surface water determined here are in 277 
the range of those determined in effluent (~10 – 50 ng L-1) [28]. Additionally, spread of 278 
sludge and bio-solids including [29] reclaimed wastewater for irrigation from WWTPs 279 
onto agricultural land could lead to further surface run-off or leaching of 280 
pharmaceuticals and controlled substances into surface waters [30]. For pesticides, 281 
run-off and leaching (including possible re-mobilisation) are the potential sources 282 
relating the compounds detected herein [31].   283 
 284 
3.2.1 Illicit drugs, drugs of abuse and life-style related compounds 285 
Interestingly, the most frequently detected and highest concentration compounds in 286 
biolgoical samples were illicit drugs and/or drugs of abuse, such as cocaine, ketamine, 287 
alprazolam and diazepam. Cocaine was detected and quantified in all biota samples 288 
across all 15 sites at an average of 5.9 ± 4.3 ng g-1 (max. 30.8 ng g-1). Average 289 
concentrations of cocaine between different catchments did not vary significantly 290 
showing widespread contamination (Alde = 6.9, Deben = 6.9, Gipping = 6.8, Stour = 291 
6.2 & Waveney = 4.2 ng g-1). Lidocaine was the second most frequently detected 292 
compound in the biota samples that can be used as an adulterant to ‘cut’ cocaine due 293 
to its synergistic effects [32] or is used as local anaesthetic. Another commonly used 294 
adulterant for cocaine use is levamisole. This compound, however, was not frequently 295 
detected in either biota or surface water samples. However, illicit compounds are 296 
rarely monitored in aquatic fauna, with only one previous occurrence study in the 297 
literature that determined cocaine at an average concentration of 0.28 ng g-1 dw in 298 
Mytilus spp [3]. A separate investigation into the bioaccumulation potential of cocaine 299 
in European eels (Anguilla anguilla) in Italy revealed tissue concentrations ranging 300 
from 0.47 – 30.5 pg g-1 ww depending on tissue type at an exposure concentration of 301 
15 
 
20 ng L-1 [33]. However, eels were not studied as part of this or previous works in our 302 
laboratory. The source of the widespread cocaine contamination is unclear. Scattered 303 
throughout the catchments of these Suffolk rivers are small wastewater treatment 304 
plants that will discharge into the water courses. However, secondary wastewater 305 
treatment with activated sludge are efficient at removing cocaine (~90% [34]), whereas 306 
trickling filters are less efficient (35-37% removal [34]). The dispersal of deactivated 307 
sewage sludge onto farmland as a fertiliser is unlikely to be a primary source and 308 
concentrations of cocaine in sludge have been reported as low, at ~3 ng g-1 [35]. The 309 
primary metabolite of cocaine, benzoylecgonine (BZE) was also frequently detected, 310 
but often below the LOQ in both water and biological extracts. The concentration of 311 
cocaine determined in surface water samples was also below the LOQ for all sites and 312 
previous studies in the UK have often determined cocaine at ~1-10 ng L-1 in surface 313 
water [28, 36]. The ratio between cocaine to BZE is also important to consider and 314 
may potentially indicate the source of input into the environment. For example, in 315 
wastewater analysed from London in 2014, the ratio between cocaine and BZE was 316 
0.51 ±0.09 in influent, but was very different and more variable in effluents measured 317 
on the same days (2.60 ±1.46) [28]. Therefore, it is expected that the ratio between 318 
cocaine and BZE in river water catchments should be similar to effluent ratios but this 319 
was not the case for London, where the ratio for cocaine:BZE over six weeks of daily 320 
monitoring was 0.21 ±0.1 (similar to influent ratios) [28]. Thus, it is proposed that the 321 
input of cocaine into surface waters in the UK is likely due to combined sewer overflow 322 
events or leakage from sewer misconnections and cesspit overflow. Interestingly, the 323 
ratio in the biota samples measured here (mean: 5.00) indicated that cocaine had 324 
preferential accumulation over its demethylated metabolite, BZE.  325 
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 Tramadol was frequently detected in surface water and reached the highest 326 
measured concentration across the sites of 382.2 ng L-1. This compound has 327 
previously been detected in UK rivers ranging from <30 ng L-1 to 5970 ng L-1 [28, 36]. 328 
Effect assessments studies demonstrate lowest observed effects concentrations 329 
(LOEC) of 10 µg L-1 in fish embryo tests [37]. Occurrence of this compound here was 330 
infrequent with a maximum measured concentration of 7.5 ng g-1. Field-derived 331 
bioaccumulation studies have suggested that bioaccumulation is low with BAFs <5 332 
and tissue concentrations in fish were <6 ng g-1 [38]. Ketamine was also frequently 333 
detected in biolgocal and surface water samples here, with concentrations reaching 334 
up to 22.5 ng g-1 and 205 ng L-1. However, to the authors’ knowledge, ketamine has 335 
not been previously reported in aquatic fauna, but surface water concentrations have 336 
been measured at 12 ng L-1 [28].  337 
The benzodiazepines are a class of compounds used for medicinal purposes 338 
but are also misused/abused. Alprazolam, diazepam and temazepam was determined 339 
at 2.7 ±1.3 ng g-1, 1.5 ±1.4 ng g-1 and 2.4 ±2.3 ng g-1, respectively. Lorazepam, 340 
oxazepam and nordiazepam were infrequently detected. Our previous work has 341 
shown that diazepam and temazepam have a low potential to accumulate in G. pulex 342 
and which are capable of rapid biotransformation and elimination of these compounds 343 
[39]. In surface water samples, diazepam was infrequently detected and often 344 
occurred at <1 ng L-1. Alprazolam was also infrequently detected and below the LOQ. 345 
The average concentrations of the remaining benzodiazepines were 9.0 ±9.4 ng L-1 346 
(temazepam), 5.2 ±3.5 ng L-1 (oxazepam), 4.8 ±3.3 ng L-1 (lorazepam) and 2.2 ±0.8 347 
ng L-1 (nordiazepam).  348 
 Synthetic cathinones including methedrone, mephedrone, methcathinone and 349 
4-fluoromethcathinone were not detected at any site in the biota samples. However, 350 
17 
 
methcathinone was detected below the LOQ at a small number of sites in surface 351 
water samples from the river catchments of Waveney, Deben and Alde. Cathinones 352 
are psychoactive substances and their consumption across the UK and Europe formed 353 
the basis of several occurrence studies in surface water and wastewater [40]. Nicotine 354 
was determined in surface water samples up to 342.8 ng L-1 and was also detected in 355 
38 % of the biota samples ranging from <LOQ to 16.5 ng g-1. Its primary metabolite, 356 
cotinine, was also detected in biota and surface water samples, but less frequently 357 
and at lower concentrations. Based on human metabolism, the expected ratio of 358 
nicotine to cotinine would range between 0.65 – 1.00 [41]. However, for surface water 359 
samples the average ratio of nicotine:cotinine was 7.61 and in biota samples was 2.39. 360 
The higher concentration of nicotine to cotinine has been reported previously for 361 
effluent wastewater [42] and a similar ratio to surface water can be estimated (6.3) 362 
from reported concentrations in influent wastewater samples [43]. These types of 363 
compounds are useful to monitor in the environment as they can serve as indicators 364 
of population health and lifestyle choices. Previous studies have identified markers of 365 
alcohol consumption such as ethyl sulfate [44]. Whilst other sewage epidemiology 366 
studies have used drug concentrations in wastewater to relate back to recreational 367 
drug use of the population [45]. In addition to the association with human health, these 368 
drugs are often not monitored in biota and so any potential risk from exposed aquatic 369 
wildlife is poorly understood. The reason for poor exposure and hazard assessment is 370 
likely to stem from that many of these substances are also medicines and therefore 371 
will be considered ‘legacy’ products, which do not require ERA. Interestingly, seven of 372 
the top ten most frequently detected compounds in biota samples are related to illicit 373 
drugs/drugs of abuse. The risk of these compounds is not well understood due to the 374 
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lack of literature, but as these compounds are all psychoactive, any effects on fauna 375 
may be elicited through behavioural changes [46, 47]. 376 
 377 
3.2.2 Pharmaceuticals 378 
The most frequently detected pharmaceutical in both biota and surface water samples 379 
was carbamazepine. This compound has been shown to occur in G. pulex, surface 380 
water and sludges samples [5, 29]. Measured concentrations in the biota samples 381 
ranged from <LOQ to 31.5 ng g-1 and in surface water, the concentrations ranged from 382 
<LOQ to 272 ng L-1. The highest surface water concentrations were measured at Site 383 
1 (average: 225 ng L-1) which also corresponded to relatively high concentrations 384 
measured in G. pulex with an average of 16.3 ng g-1. Higher concentrations of 385 
carbamazepine were determined at site 6 and 8 for the Ephemera vulgata and Asellus 386 
aquaticus samples. Site 8 surface water concentration of carbamazepine were below 387 
the LOQ and site 16 averaged 92.6 ng L-1. This may suggest that E. vulgata and A. 388 
aquaticus are more sensitive than G. pulex to the accumulation of carbamazepine. 389 
However, surface water concentrations often do not translate well into internal 390 
concentrations for several reasons such as temporal variation, spatial variation and 391 
migration behaviour of aquatic fauna among other influences. Additionally, the main 392 
human metabolite of carbamazepine, CBZ-epoxide, was detected across 30% of the 393 
biota samples. This metabolite has been detected and measured in invertebrate 394 
species including G. pulex and Mytilus galloprovincialis showing conservation of 395 
biotransformation pathways [39, 48]. The increased concentration of carbamazepine 396 
at Site 1 G. pulex samples also coincided with increased detection of the epoxide 397 
metabolite. However, the metabolite was not detected in E. vulgata larvae and was 398 
minimal in A. aquaticus despite higher concentrations of carbamazepine measured in 399 
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these species. This may indicate a different sensitivity of these organisms to 400 
carbamazepine through toxicokinetics, where biotransformation and elimination routes 401 
are different. The mean ratio of carbamazepine to the epoxide metabolite was 8.9 in 402 
the biota samples, which is closer to observed human therapeutic ratios of ~5 [49].  403 
 The highest measured pharmaceutical concentration across the biota samples 404 
alone was for the beta-blocker propranolol (45.5 ng g-1 at Site 4). The concentrations 405 
of propranolol in surface water ranged from <LOQ to a maximum of 27 ng L-1, which 406 
is significantly below (two orders of magnitude) the reported no-observed effects 407 
(NOEC) and lowest-observed effects (LOEC) in fish and invertebrates [50, 51]. Other 408 
beta-blockers were detected at lower concentrations and less frequently which 409 
included betaxolol, salbutamol and metoprolol. The remaining beta-blockers included 410 
in this method, were not detected at any site for the biota samples (timolol, nadolol 411 
and bisoprolol). However, for surface water samples, bisoprolol was detected 412 
frequently across all river catchments, with metoprolol and the beta-agonist salbutamol 413 
less frequently detected.  414 
 The selective serotonin reuptake inhibitor citalopram was frequently detected 415 
in biota samples at Site 7, Site 1 and Site 20, with concentrations ranging from 3.8 to 416 
36.6 ng g-1. The maximum concentration was determined to be 42.4 ng g-1 at Site 14. 417 
Surface water concentrations of citalopram were often below the LOQ but were 418 
determined at higher average concentrations of 14.7±10.6 ng L-1 for Site 1, Site 7 and 419 
Site 20. Citalopram has been previously determined up to concentrations of 20.6 ng 420 
g-1 in bivalves (Mytilus spp.) [52], 0.212 ng g-1 in fish brain tissue (Catostomus 421 
commersonii) [53] and more recently was reported to reach concentrations of ~6000 422 
ng g-1 in Hydropsyche spp [54]. From the literature, citalopram has been observed to 423 
have low accumulation factors ranging from less <7 to 47 [38, 55]. Based on 424 
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occurrence data presented here, it would also likely have a low bioaccumulation factor. 425 
Furthermore, the analytical method here could not distinguish between the 426 
enantiomeric forms of citalopram with the S-enantiomer responsible for the 427 
pharmacological action where it has also been suggested that R-enantiomer inhibits 428 
this therapeutic effect. Other researchers have shown that racemic mixtures of 429 
pharmaceuticals can often be enriched by either human or microbial biotransformation 430 
or may remain as racemates if biodegradation does not occur [56]. Many of the 431 
pharmaceuticals reported here display stereoisomerism, which is poorly understood 432 
in terms of environmental risk, and is often overlooked in both fate and effect-based 433 
studies [56]. The most frequently detected antibiotic was trimethoprim with measured 434 
concentrations ranging from 1.5 – 4.6 ng g-1. Other antibiotics detected included three 435 
sulphonamides: sulfamethazine; sulfapyridine; and sulfadimethoxine. However, 436 
sulfamethazine was not quantifiable in any sample and sulfadimethoxine was only 437 
measured once reaching 1.7 ng g-1. Bioconcentration studies for sulfamethazine in 438 
Oryzias melastigma have ranged from <1 – 145 depending on tissue and biological 439 
sex indicating that there is no or little potential for bioaccumulation [39, 57]. The low 440 
bioaccumulation is likely to stem from the polarity (logP = 0.44, logD8 = 0.1) and 441 
ionisation state of the drug which has been shown to influence uptake in fish and 442 
invertebrates [20, 58, 59]. Sulfapyridine, was also infrequently detected except at Site 443 
1, with an average concentration of 4.8 ng g-1. The low occurrence of the 444 
sulphonamides in biota is likely due to the high polarity and metabolism of these 445 
compounds.   446 
 447 
3.2.3 Pesticides 448 
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Neonicotinoids have gained much attention recently, with the EU now enforcing a near 449 
total ban on their use [60]. Few studies have determined the presence of these 450 
compounds in aquatic fauna [6, 27]. Other studies have targeted these pesticides in 451 
fish, but ultimately were not detected [7, 8]. However, these compounds do occur in 452 
surface water and averaged at 130 ng L-1 across 19 studies [61]. The compounds 453 
thiacloprid and acetamiprid were infrequently detected in surface water samples 454 
across all sites here and remained below the LOQ. Imidacloprid was not detected at 455 
any site. This agreed with a recent report on neonicotinoid contamination in UK surface 456 
waters [62], which summarised that thiacloprid and acetamiprid showed low 457 
contamination which is likely related to their low use as opposed to other 458 
neonicotinoids such as clothiandin and thiamethoxam. The qualitative data showed 459 
thiamethoxam was not detected across any sites and clothiandin was infrequently 460 
detected. This contrasts data reported for thiamethoxam in the river Waveney which 461 
showed concentrations reaching up to 1.03 µg L-1 and an average concentration of 462 
~60 ng L-1. A possible reason for the disparity between the data reported here is that 463 
the previous report was from a monitoring campaign in 2016. The samples collected 464 
in the present study were from July  2018, following the driest period record with no 465 
rain in the previous 55 days [63] suggesting that input from surface run-off and 466 
leaching was likely to be minimal. Furthermore, thiamethoxam use (area treated of 467 
arable crops) peaked in 2012 and has been followed by a decrease up to 2016 [62]. 468 
For the biota samples, acetamiprid was infrequently detected in the Waveney, but 469 
consistently detected in the catchments of Alde, Deben, Gipping and Stour. However, 470 
this compound was often below the LOQ and upon quantification showed 471 
concentrations ranging from 0.2 – 0.7 ng g-1. Thiacloprid was frequently measured in 472 
the river Waveney and Deben with average concentrations of 3.3 ± 1.6 ng g-1 and 1.6 473 
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± 1.7 ng g-1. With so little data available, meaningful comparisons of neonicotinoid 474 
concentrations with other pesticides in biota samples is difficult. Nonetheless, 475 
concentrations measured here were in the range to that of a previous investigation 476 
with thiacloprid ranging from LOQ – 21 ng g-1. Out of 10 pesticides that no longer have 477 
approval in the EU [64], a total of seven were detected in biota samples here (ametryn, 478 
dimethametryn, fenuron, propazine, aclonifen and oxycarboxine), including three that 479 
were quantifiable (ametryn, dimethametryn, fenuron). The most widespread 480 
occurrence corresponded to fenuron (0.7 – 16.1 ng g-1), oxycarboxine (qualitative) and 481 
ametryn (LOQ – 1.9 ng g-1). The compound oxycarboxine was detected with 100 % 482 
frequency (Table S5) and fenuron with 86 % frequency in biota samples. Detection of 483 
banned pesticides has recently been reported with atrazine (banned since 2003) 484 
quantified in 63 % of samples [65]. However, there is little occurrence data available 485 
for the banned pesticides detected here, but several banned pesticides including 486 
fenuron, atrazine and simazine have been found to occur in UK groundwaters [66]. 487 
The detection of these compounds in the environment might be explained by 488 
persistence and subsequent release of these compounds in sediments and/or soil [65].  489 
 490 
3.3 Estimating the toxic or effect pressure of contaminants in the aquatic environment 491 
It has been suggested that internalised concentrations of contaminants are more 492 
appropriate for the assessment of potential risk in the environment than effect 493 
thresholds based on external exposure (i.e. in the water) [1]. From the data here, we 494 
estimated the internal toxic pressure (pesticides) or ‘effect pressure’ 495 
(pharmaceuticals/drugs of abuse) [6] using predicted bioconcentration data [20, 21] 496 
and the available effect data (EC50 or CEC) [18, 24]. This approach is analogous to 497 
risk quotients (RQ) estimated from predicted environmental concentrations and 498 
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predicted no effect concentration (PEC/PNEC). The logTUint for the pesticides 499 
determined ranged from approximately -7 to -2 (Figure 5a), where previous studies 500 
have indicated that a logTU threshold based on water concentrations for pesticides of 501 
-3 and higher can elicit adverse effects [13-15], Only one compound (oxamyl) was 502 
above the threshold of logTU ≥ -3. This compound is still approved for use in the EU 503 
and may indicate the potential for risk at the concentrations measured in the biota 504 
samples. The EC50 was based on D. magna acute toxicity studies which have been 505 
shown to be the most sensitive across all aquatic organisms that were tested. 506 
However, the risk based on available evidence was concluded to be low [67]. The 507 
neonicotinoids acetamiprid and thiacloprid showed low logTUint values of less than -508 
4.6. In comparison, Munz et al. [6] estimated thiacloprid to have a higher logTUint in G. 509 
pulex than reported here and exceeded the threshold for several of the measured 510 
samples. The disparity between the estimation of toxic pressure is that concentrations 511 
of thiacloprid determined here in G. pulex, were relatively lower. In addition, the EC50 512 
value used in this study was ~10-fold larger than in the previous study. For this 513 
approach EC50 data is often not well distributed and can vary depending on the end 514 
point, experimental conditions and species used. For these reasons, it may be more 515 
appropriate to include a range of the EC50 data available or review the quality of the 516 
available literature data to give more reliable estimation of toxic pressure [68].  517 
 The logTU threshold value is not likely to be directly applicable to 518 
pharmaceuticals, which are likely to be less toxic than pesticides by nature of their 519 
design. Thus, for this work we use the term ‘effect units’ (EUint) for pharmaceuticals, 520 
as thresholds that might be associated to toxicity are unknown. Instead, CEC data are 521 
used instead of EC50int, but in themselves are not a toxicity endpoint. Substantial 522 
further work would be needed to determine possible thresholds associated with TU for 523 
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different contaminant classes and for internalised concentrations, as opposed to 524 
surface water concentrations. Larger effect pressures were mainly associated with 525 
pharmaceuticals such as haloperidol that showed the highest EUint (Figure 5b). The 526 
reason haloperidol has high EUint values is due to the low CEC of 6.5 ng L-1 based on 527 
human therapeutic plasma concentrations of 1 ng mL-1. Additional antipsychotic drugs 528 
including chloropromazine (CEC = 36 ng L-1) and risperidone (CEC = 129 ng L-1) were 529 
also estimated to have a high toxic pressure. Other neuroactive pharmaceuticals 530 
including antidepressants and anxiolytics such as alprazolam, lorazepam, citalopram 531 
and busipirone also showed higher EUint which may indicate that these types of 532 
contaminants have a greater risk in the environment which has been previously 533 
suggested from surface water risk assessments [69]. This may be particularly 534 
apparent when focussing on sub-lethal endpoints such as altered behaviour 535 
phenotypes [70]. Despite its widespread occurrence, cocaine showed a low potential 536 
for an effect based on its CEC and BCF. The benefits of using CECs for 537 
pharmaceuticals is that the availability of data for human therapeutic values is greater 538 
than ecotoxicological data. In particular, EC50 data for ‘legacy’ pharmaceuticals is 539 
critically lacking. However, the use of CECs has some limitations in that a therapeutic 540 
effect does not necessarily correspond to an adverse effect and that the onset of 541 
pharmacological action may differ between humans and non-target organisms [18, 542 
71]. Furthermore, molecular targets of pharmacological action are not always 543 
conserved between species and bioavailability may also differ between them [19, 71].  544 
 545 
4. Conclusion 546 
Cocaine was the most widespread contaminant found in both surface water and biota 547 
samples, but no conclusions can be drawn about the potential for adverse effects of 548 
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this compound without further work. Out of 67 compounds that could be quantitatively 549 
determined 56 were measured with the higher frequencies of detection for cocaine 550 
(100%), lidocaine (95%), alprazolam (88%), fenuron (86%) and ketamine (76%) in 551 
biota samples. In comparison for surface water samples, 50 compounds were 552 
measured including cocaine, carbamazepine, fenuron, ketamine and lidocaine, 553 
propranolol and tramadol that all had 100% detection frequency. The detection of 554 
several pesticides that no longer have approval in the EU warrants further 555 
investigation, as the sources for their input into the environment remain unclear. The 556 
total body burden of the contaminants determined in the biota samples ranged from 557 
6.5 ng g-1 to 163.5 ng g-1 dw depending on the site. The total body burden is also an 558 
underestimate when accounting for the qualitative data, in addition to contaminants 559 
that were not targeted for in this study (including biotransformation products). Overall, 560 
whilst toxic pressure and effect pressure estimates were low in this study, the 561 
contribution of total body burden, the variability in effect data available (including lack 562 
of internal effect data) and thresholds for toxic/effect pressure are limitations to 563 
improving environmental risk assessment based on this approach. Nevertheless, the 564 
approach does support prioritisation of contaminants in the environment through the 565 
use of biomonitoring to reveal both the exposure, hazard and, ultimately, risk.  566 
 567 
Acknowledgements  568 
This work was conducted under funding from the Biotechnology and Biological 569 
Sciences Research Council (BBSRC) iNVERTOX project (Reference BB/P005187/1). 570 
Funding bodies played no role in the design of the study or decision to publish. The 571 
authors declare no financial conflict of interest. The authors would also like to 572 
26 
 
acknowledge and thank Mark Bowler for his help with the presentation of the GIS data 573 
for the sampling sites. 574 
References 575 
1. Miller, T.H., et al., A review of the pharmaceutical exposome in aquatic fauna. Environmental 576 
Pollution, 2018. 239: p. 129-146. 577 
2. Barceló, D., Occurrence, handling and chromatographic determination of pesticides in the 578 
aquatic environment. A review. Analyst, 1991. 116(7): p. 681-689. 579 
3. Dodder, N.G., et al., Occurrence of contaminants of emerging concern in mussels (Mytilus 580 
spp.) along the California coast and the influence of land use, storm water discharge, and 581 
treated wastewater effluent. Marine Pollution Bulletin, 2014. 81(2): p. 340-346. 582 
4. Inostroza, P.A., et al., Body burden of pesticides and wastewater-derived pollutants on 583 
freshwater invertebrates: Method development and application in the Danube River. 584 
Environmental Pollution, 2016. 214: p. 77-85. 585 
5. Miller, T.H., et al., Pharmaceuticals in the freshwater invertebrate, Gammarus pulex, 586 
determined using pulverised liquid extraction, solid phase extraction and liquid 587 
chromatography–tandem mass spectrometry. Science of The Total Environment, 2015. 511: 588 
p. 153-160. 589 
6. Munz, N.A., et al., Internal Concentrations in Gammarids Reveal Increased Risk of Organic 590 
Micropollutants in Wastewater-Impacted Streams. Environmental Science & Technology, 591 
2018. 52(18): p. 10347-10358. 592 
7. Jabeen, F., et al., Examining pyrethroids, carbamates and neonicotenoids in fish, water and 593 
sediments from the Indus River for potential health risks. Environmental Monitoring and 594 
Assessment, 2015. 187(2): p. 29. 595 
8. Masiá, A., et al., Screening of currently used pesticides in water, sediments and biota of the 596 
Guadalquivir River Basin (Spain). Journal of Hazardous Materials, 2013. 263: p. 95-104. 597 
9. Varol, M. and M.R. Sünbül, Organochlorine pesticide, antibiotic and heavy metal residues in 598 
mussel, crayfish and fish species from a reservoir on the Euphrates River, Turkey. 599 
Environmental Pollution, 2017. 230: p. 311-319. 600 
10. Junqué, E., et al., Drivers of the accumulation of mercury and organochlorine pollutants in 601 
Mediterranean lean fish and dietary significance. Science of The Total Environment, 2018. 602 
634: p. 170-180. 603 
11. Carson, R., Silent spring. 2002: Houghton Mifflin Harcourt. 604 
12. Commission, E., 2006/507/EC: Council Decision of 14 October 2004 concerning the 605 
conclusion, on behalf of the European Community, of the Stockholm Convention on Persistent 606 
Organic Pollutants. Official Journal of the European Union, 2004. L 209. 607 
13. Beketov, M.A., et al., SPEAR indicates pesticide effects in streams – Comparative use of 608 
species- and family-level biomonitoring data. Environmental Pollution, 2009. 157(6): p. 1841-609 
1848. 610 
14. Schäfer, R.B., et al., Effects of pesticides on community structure and ecosystem functions in 611 
agricultural streams of three biogeographical regions in Europe. Science of The Total 612 
Environment, 2007. 382(2): p. 272-285. 613 
15. Liess, M. and P.C.V.D. Ohe, Analyzing effects of pesticides on invertebrate communities in 614 
streams. Environmental Toxicology and Chemistry, 2005. 24(4): p. 954-965. 615 
16. González-Alonso, S., et al., Occurrence of pharmaceutical, recreational and psychotropic drug 616 
residues in surface water on the northern Antarctic Peninsula region. Environmental 617 
Pollution, 2017. 229: p. 241-254. 618 
17. de Zwart, D., Observed regularities in species sensitivity distributions for aquatic species, in 619 
Species sensitivity distributions in ecotoxicology. 2001, CRC Press. p. 157-178. 620 
27 
 
18. Fick, J., et al., Predicted critical environmental concentrations for 500 pharmaceuticals. 621 
Regulatory Toxicology and Pharmacology, 2010. 58(3): p. 516-523. 622 
19. Cook, J.C., J.F. Ericson, and R.T. Williams, A Theoretical Model for Utilizing Mammalian 623 
Pharmacology and Safety Data to Prioritize Potential Impacts of Human Pharmaceuticals to 624 
Fish AU - Huggett, D. B. Human and Ecological Risk Assessment: An International Journal, 625 
2003. 9(7): p. 1789-1799. 626 
20. Miller, T.H., et al., Prediction of bioconcentration factors in fish and invertebrates using 627 
machine learning. Science of The Total Environment, 2019. 648: p. 80-89. 628 
21. Agency, U.S.E.P., Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. . 629 
2019, United States Environmental Protection Agency: Washington, DC, USA. 630 
22. Baker, D.R. and B. Kasprzyk-Hordern, Critical evaluation of methodology commonly used in 631 
sample collection, storage and preparation for the analysis of pharmaceuticals and illicit 632 
drugs in surface water and wastewater by solid phase extraction and liquid 633 
chromatography–mass spectrometry. Journal of Chromatography A, 2011. 1218(44): p. 634 
8036-8059. 635 
23. Aboulfadl, K., et al., Time-dependent integrity during storage of natural surface water 636 
samples for the trace analysis of pharmaceutical products, feminizing hormones and 637 
pesticides. 2010. 4(1): p. 10. 638 
24. Hertfordshire, U.o. Pesticide Properties Database. 2019; Available from: 639 
https://sitem.herts.ac.uk/aeru/ppdb/en/index.htm. 640 
25. Althakafy, J.T., et al., Determination of selected emerging contaminants in freshwater 641 
invertebrates using a universal extraction technique and liquid chromatography accurate 642 
mass spectrometry. Journal of Separation Science, 2018. 41(19): p. 3706-3715. 643 
26. Mills, G.A., et al., Measurement of environmental pollutants using passive sampling devices–644 
an updated commentary on the current state of the art. Environmental Science: Processes & 645 
Impacts, 2014. 16(3): p. 369-373. 646 
27. Shahid, N., et al., Pesticide Body Burden of the Crustacean Gammarus pulex as a Measure of 647 
Toxic Pressure in Agricultural Streams. Environmental Science & Technology, 2018. 52(14): p. 648 
7823-7832. 649 
28. Munro, K., et al., Evaluation of combined sewer overflow impacts on short-term 650 
pharmaceutical and illicit drug occurrence in a heavily urbanised tidal river catchment 651 
(London, UK). Science of The Total Environment, 2019. 657: p. 1099-1111. 652 
29. Barron, L., J. Tobin, and B. Paull, Multi-residue determination of pharmaceuticals in sludge 653 
and sludge enriched soils using pressurized liquid extraction, solid phase extraction and liquid 654 
chromatography with tandem mass spectrometry. Journal of Environmental Monitoring, 655 
2008. 10(3): p. 353-361. 656 
30. Carter, L.J., et al., Emerging investigator series: towards a framework for establishing the 657 
impacts of pharmaceuticals in wastewater irrigation systems on agro-ecosystems and human 658 
health. 2019. 659 
31. Huber, A., M. Bach, and H.G. Frede, Pollution of surface waters with pesticides in Germany: 660 
modeling non-point source inputs. Agriculture, Ecosystems & Environment, 2000. 80(3): p. 661 
191-204. 662 
32. Barat, S.A. and M.S. Abdel-Rahman, Cocaine and lidocaine in combination are synergistic 663 
convulsants. Brain Research, 1996. 742(1): p. 157-162. 664 
33. Capaldo, A., et al., Presence of Cocaine in the Tissues of the European Eel, Anguilla anguilla, 665 
Exposed to Environmental Cocaine Concentrations. Water, Air, & Soil Pollution, 2012. 223(5): 666 
p. 2137-2143. 667 
34. Yadav, M.K., et al., Occurrence of illicit drugs in water and wastewater and their removal 668 
during wastewater treatment. Water Research, 2017. 124: p. 713-727. 669 
28 
 
35. Petrie, B., et al., Multi-residue analysis of 90 emerging contaminants in liquid and solid 670 
environmental matrices by ultra-high-performance liquid chromatography tandem mass 671 
spectrometry. Journal of Chromatography A, 2016. 1431: p. 64-78. 672 
36. Kasprzyk-Hordern, B., R.M. Dinsdale, and A.J. Guwy, The occurrence of pharmaceuticals, 673 
personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, 674 
UK. Water Research, 2008. 42(13): p. 3498-3518. 675 
37. Sehonova, P., et al., Toxicity of naproxen sodium and its mixture with tramadol hydrochloride 676 
on fish early life stages. Chemosphere, 2017. 188: p. 414-423. 677 
38. Grabicova, K., et al., Tissue-specific bioconcentration of antidepressants in fish exposed to 678 
effluent from a municipal sewage treatment plant. Science of The Total Environment, 2014. 679 
488-489: p. 46-50. 680 
39. Miller, T.H., et al., Uptake, biotransformation and elimination of selected pharmaceuticals in 681 
a freshwater invertebrate measured using liquid chromatography tandem mass 682 
spectrometry. Chemosphere, 2017. 183: p. 389-400. 683 
40. Baz-Lomba, J.A., M.J. Reid, and K.V. Thomas, Target and suspect screening of psychoactive 684 
substances in sewage-based samples by UHPLC-QTOF. Analytica Chimica Acta, 2016. 914: p. 685 
81-90. 686 
41. Benowitz, N.L., J. Hukkanen, and P. Jacob, Nicotine Chemistry, Metabolism, Kinetics and 687 
Biomarkers, in Nicotine Psychopharmacology, J.E. Henningfield, E.D. London, and S. Pogun, 688 
Editors. 2009, Springer Berlin Heidelberg: Berlin, Heidelberg. p. 29-60. 689 
42. Bueno, M.J.M., et al., Occurrence and persistence of organic emerging contaminants and 690 
priority pollutants in five sewage treatment plants of Spain: Two years pilot survey 691 
monitoring. Environmental Pollution, 2012. 164: p. 267-273. 692 
43. Huerta-Fontela, M., et al., Occurrence of psychoactive stimulatory drugs in wastewaters in 693 
north-eastern Spain. Science of The Total Environment, 2008. 397(1): p. 31-40. 694 
44. Ryu, Y., et al., Comparative measurement and quantitative risk assessment of alcohol 695 
consumption through wastewater-based epidemiology: An international study in 20 cities. 696 
Science of The Total Environment, 2016. 565: p. 977-983. 697 
45. van Nuijs, A.L.N., et al., Sewage epidemiology — A real-time approach to estimate the 698 
consumption of illicit drugs in Brussels, Belgium. Environment International, 2011. 37(3): p. 699 
612-621. 700 
46. Bossus, M.C., et al., Behavioural and transcriptional changes in the amphipod 701 
Echinogammarus marinus exposed to two antidepressants, fluoxetine and sertraline. Aquatic 702 
Toxicology, 2014. 151: p. 46-56. 703 
47. Brodin, T., et al., Dilute Concentrations of a Psychiatric Drug Alter Behavior of Fish from 704 
Natural Populations. Science, 2013. 339(6121): p. 814. 705 
48. Boillot, C., et al., In vivo exposure of marine mussels to carbamazepine and 10-hydroxy-706 
10,11-dihydro-carbamazepine: Bioconcentration and metabolization. Science of The Total 707 
Environment, 2015. 532: p. 564-570. 708 
49. Potter, J.M. and A. Donnelly, Carbamazepine-10, 11-epoxide in therapeutic drug monitoring. 709 
Therapeutic drug monitoring, 1998. 20(6): p. 652-657. 710 
50. Huggett, D.B., et al., Toxicity of Select Beta Adrenergic Receptor-Blocking Pharmaceuticals (B-711 
Blockers) on Aquatic Organisms. Archives of Environmental Contamination and Toxicology, 712 
2002. 43(2): p. 229-235. 713 
51. Owen, S.F., et al., Uptake of propranolol, a cardiovascular pharmaceutical, from water into 714 
fish plasma and its effects on growth and organ biometry. Aquatic Toxicology, 2009. 93(4): p. 715 
217-224. 716 
52. Álvarez-Muñoz, D., et al., Occurrence of pharmaceuticals and endocrine disrupting 717 
compounds in macroalgaes, bivalves, and fish from coastal areas in Europe. Environmental 718 
Research, 2015. 143: p. 56-64. 719 
29 
 
53. Schultz, M.M., et al., Antidepressant Pharmaceuticals in Two U.S. Effluent-Impacted Streams: 720 
Occurrence and Fate in Water and Sediment, and Selective Uptake in Fish Neural Tissue. 721 
Environmental Science & Technology, 2010. 44(6): p. 1918-1925. 722 
54. Richmond, E.K., et al., A diverse suite of pharmaceuticals contaminates stream and riparian 723 
food webs. Nature Communications, 2018. 9(1): p. 4491. 724 
55. Lajeunesse, A., et al., Distribution of antidepressants and their metabolites in brook trout 725 
exposed to municipal wastewaters before and after ozone treatment – Evidence of biological 726 
effects. Chemosphere, 2011. 83(4): p. 564-571. 727 
56. Evans, S., J. Bagnall, and B. Kasprzyk-Hordern, Enantiomeric profiling of a chemically diverse 728 
mixture of chiral pharmaceuticals in urban water. Environmental Pollution, 2017. 230: p. 729 
368-377. 730 
57. Hou, X., et al., Bioconcentration and Elimination of Sulfamethazine and Its Main Metabolite 731 
in Sturgeon (Acipenser schrenkii). Journal of Agricultural and Food Chemistry, 2003. 51(26): 732 
p. 7725-7729. 733 
58. Chang, E.D., et al., The Use of Molecular Descriptors To Model Pharmaceutical Uptake by a 734 
Fish Primary Gill Cell Culture Epithelium. Environmental Science & Technology, 2018. 735 
59. Meredith-Williams, M., et al., Uptake and depuration of pharmaceuticals in aquatic 736 
invertebrates. Environmental Pollution, 2012. 165: p. 250-258. 737 
60. Commission, E., Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 738 
implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council 739 
as regards the list of approved active substances Text with EEA relevance. Official Journal of 740 
the European Union, 2011. L 153. 741 
61. Morrissey, C.A., et al., Neonicotinoid contamination of global surface waters and associated 742 
risk to aquatic invertebrates: A review. Environment International, 2015. 74: p. 291-303. 743 
62. Shardlow, M., Neonicotinoid Insecticides in British Freshwaters. 2017. 744 
63. Office, M. Summer 2018. 2018; Available from: 745 
https://www.metoffice.gov.uk/climate/uk/summaries/2018/summer. 746 
64. Commission, E., Regulation (EC) No 1107/2009 of the European Parliament and of the 747 
Council of 21 October 2009 concerning the placing of plant protection products on the 748 
market and repealing Council Directives 79/117/EEC and 91/414/EEC. Official Journal of the 749 
European Union, 2009. L 309. 750 
65. Bernard, M., et al., Combination of passive and grab sampling strategies improves the 751 
assessment of pesticide occurrence and contamination levels in a large-scale watershed. 752 
Science of The Total Environment, 2019. 651: p. 684-695. 753 
66. Forum, P., Pesticides in the UK: The 2015 report on the impacts and sustainable use of 754 
pesticides. 2015. 755 
67. Authority, E.F.S., Conclusion regarding the peer review of the pesticide risk assessment of the 756 
active substance oxamyl. EFSA Journal, 2005. 3(3): p. 26r. 757 
68. Küster, A., et al., Regulatory demands on data quality for the environmental risk assessment 758 
of pharmaceuticals. Regulatory Toxicology and Pharmacology, 2009. 55(3): p. 276-280. 759 
69. Sanderson, H., et al., Ranking and prioritization of environmental risks of pharmaceuticals in 760 
surface waters. Regulatory Toxicology and Pharmacology, 2004. 39(2): p. 158-183. 761 
70. Fong, P.P. and A.T. Ford, The biological effects of antidepressants on the molluscs and 762 
crustaceans: A review. Aquatic Toxicology, 2014. 151: p. 4-13. 763 
71. Roos, V., et al., Prioritising pharmaceuticals for environmental risk assessment: Towards 764 
adequate and feasible first-tier selection. Science of The Total Environment, 2012. 421-422: 765 
p. 102-110. 766 
 
 
30 
 
 
 
31 
 
Table 1:  Method performance assessment for G. pulex covering all stages of the analytical workflow. Repeatability was assessed 
by intra-day (3 concentrations) and inter-day precision (1 concentration) and is expressed by relative standard deviation (RSD). 
Matrix effects were assessed at 50 ng g-1 (n=5) by comparing post-extraction spiked matrix matched standards to a pure analytical 
standard and negative values indicate suppression effects.      
 
Matrix Effect Recovery Inter-day LOQ LOD
 (%) tR (min) (%) 25 ng g
-1
50 ng g
-1
100 ng g
-1
 Precision (%RSD)  25 ng g
-1
SD 50 ng g
-1
SD100 ng g
-1
SD Linearity Range ng g
-1
ng g
-1
Compound (n=5) SD (n=5) SD (n=5) (n=3) (n=5) (n=3) (n=3) (n=3) (n=3) (n=3) R
2
ng g
-1
(n=6) (n=6)
4-fluoromethcathinone -44 ± 5 6.92 ± 0.014 45 14 13 14 19 75 ± 12 92 ± 30 117 ± 15 0.9930 3.7-500 3.7 1.2
Acetamiprid -57 ± 8 6.92 ± 0.001 92 1 15 7 9 102 ± 1 98 ± 6 96 ± 7 0.9997 0.2-500 0.2 0.08
Alprazolam -46 ± 10 10.58 ± 0.011 71 8 7 6 13 80 ± 7 80 ± 12 90 ± 6 0.9976 1.2-250 1.2 0.4
Ametryn -62 ± 8 11.76 ± 0.002 80 12 8 8 7 72 ± 9 111 ± 8 96 ± 12 0.9950 1.3-250 1.3 0.4
Antipyrin -52 ± 6 5.43 ± 0.001 72 1* 10 7 16 84 ± 11 125 ± 17 126 ± 9 0.9973 6.8-500 6.8 1.4
Benzotropine -70 ± 8 11.89 ± 0.002 65 9 5 6 15 74 ± 7 106 ± 12 97 ± 5 0.9901 0.6-250 0.6 0.2
Benzoylecgonine -58 ± 2 4.65 ± 0.017 71 4 7 8 15 102 ± 9 95 ± 11 116 ± 0 0.9982 0.6-500 0.6 0.2
Betaxolol -53 ± 8 10.29 ± 0.014 94 3 11 3 22 100 ± 18 88 ± 18 80 ± 4 0.9944 0.5-250 0.5 0.2
Bezafibrate -61 ± 6 6.96 ± 0.016 63 8 13 6 15 89 ± 12 97 ± 7 108 ± 6 0.9984 9.2-500 9.2 3.0
Bisoprolol -28 ± 17 9.54 ± 0.066 93 5 6 10 13 85 ± 1 101 ± 12 86 ± 8 0.9898 0.9-250 0.9 0.3
Busipirone -50 ± 9 11.26 ± 0.002 76 7 3 6 11 105 ± 14 97 ± 11 102 ± 12 0.9956 1.1-500 1.1 0.4
Carbamazepine -48 ± 8 9.59 ± 0.001 67 15 5 8 14 92 ± 11 86 ± 11 101 ± 4 0.9971 0.9-500 0.9 0.3
CBZ_epoxide -38 ± 3 7.70 ± 0.001 85 2 12 5 16 92 ± 2 113 ± 13 89 ± 6 0.9988 0.6-500 0.6 0.2
Chloropromazine -82 ± 5 12.66 ± 0.008 91 11 5 12 *12 99 ± 11 98 ± 28 140 ± 8 0.9928 1.8-500 1.8 5.5
Citalopram -71 ± 5 10.62 ± 0.001 76 11 10 13 24 82 ± 15 107 ± 15 78 ± 11 0.9974 2.6-250 2.6 0.9
Cocaine -37 ± 7 9.97 ± 0.014 80 8 2 1 9 96 ± 7 90 ± 11 114 ± 12 0.9973 0.5-500 0.5 0.2
Cotinine 30 ± 8 3.78 ± 0.011 62 15 8 3 13 93 ± 21 78 ± 19 109 ± 3 0.9986 2.6-500 2.6 0.8
Cycluron -34 ± 13 10.73 ± 0.002 77 2 5 7 8 109 ± 2 100 ± 8 104 ± 7 0.9997 1.5-500 1.5 0.5
Diazepam -60 ± 10 11.95 ± 0.002 87 9 11 8 13 86 ± 6 87 ± 10 88 ± 7 0.9963 0.3-250 0.3 0.1
Dimethmetryn -50 ± 10 13.02 ± 0.011 76 5 10 7 7 86 ± 3 89 ± 2 121 ± 8 0.9958 0.1-250 0.1 0.03
Diphenydramine -51 ± 9 10.94 ± 0.011 76 12 12 10 16 94 ± 11 111 ± 16 92 ± 8 0.9936 1.8-250 1.8 0.6
Ethirimol -81 ± 4 8.93 ± 0.015 81 10 9 11 11 89 ± 6 87 ± 7 94 ± 9 0.9935 1.7-500 1.7 0.6
Fenuron -56 ± 9 6.25 ± 0.016 79 9 10 3 11 105 ± 12 117 ± 10 94 ± 3 0.9991 0.6-500 0.6 0.2
Flutamide -42 ± 16 12.27 ± 0.002 80 9 7 2 16 90 ± 5 96 ± 11 75 ± 1 0.9942 0.2-250 0.2 0.1
Haloperidol -79 ± 7 11.26 ± 0.002 83 2 5 6 16 104 ± 2 92 ± 17 113 ± 8 0.9935 5.3-250 5.3 1.8
Hyrochlorothiazide -77 ± 2 3.90 ± 0.011 77 5* 13 2 19 100 ± 33 85 ± 16 118 ± 13 0.9952 2.1-500 2.1 0.7
Ketamine -56 ± 6 11.00 ± 0.002 54 10 5 7 9 85 ± 8 94 ± 2 110 ± 13 0.9949 1-500 1.0 0.3
Ketoprofen 10 ± 11 6.21 ± 0.001 69 15 9 10 14 106 ± 12 90 ± 8 117 ± 11 0.9970 15.3-500 15.3 5.0
Ketotifen -55 ± 11 10.74 ± 0.002 70 11 8 10 16 81 ± 6 104 ± 16 99 ± 10 0.9955 3.9-250 3.9 1.3
Levamisole -58 ± 4 7.76 ± 0.014 61 12 8 6 13 116 ± 13 83 ± 6 118 ± 7 0.9894 4.0-500 4.0 1.3
Levocabastine -42 ± 8 8.16 ± 0.015 97 16 10 6 15 71 ± 8 97 ± 6 113 ± 6 0.9934 0.3-250 0.3 0.1
Lidocaine -46 ± 6 11.46 ± 0.002 67 1 7 7 13 104 ± 1 91 ± 8 115 ± 8 0.9956 0.7-500 0.7 0.2
Lincomycin -18 ± 5 7.80 ± 0.009 82 5 4 9 11 112 ± 9 93 ± 8 100 ± 10 0.9968 4.5-500 4.5 1.5
Lorazepam -26 ± 14 10.44 ± 0.013 71 12 10 8 22 81 ± 6 85 ± 9 118 ± 8 0.9895 1.9-250 1.9 0.6
MDMA -59 ± 6 6.10 ± 0.042 64 6 9 10 16 111 ± 7 101 ± 9 97 ± 9 0.9995 1.9-500 1.9 0.6
Mephedrone -12 ± 6 7.65 ± 0.031 69 12 6 9 14 95 ± 8 72 ± 13 91 ± 3 0.9943 10.5-500 10.5 3.5
Mephosfolan -49 ± 12 11.52 ± 0.002 69 7 9 12 7 91 ± 14 91 ± 3 98 ± 11 0.9934 1.4-500 1.4 0.4
Methamphetamine -61 ± 5 6.25 ± 0.061 65 4 12 1 12 109 ± 16 123 ± 17 115 ± 10 0.9981 1.7-500 1.7 0.6
Methcathinone -56 ± 1 6.24 ± 0.016 43 9 13 2 15 83 ± 6 83 ± 10 117 ± 19 0.9856 3.9-250 3.9 1.3
Methedrone -63 ± 3 6.56 ± 0.015 73 1 9 15 11 70 ± 1 122 ± 8 93 ± 15 0.9991 2.9-500 2.9 1.0
Methylphenidate -74 ± 3 9.31 ± 0.055 84 15 5 10 11 89 ± 11 100 ± 15 88 ± 8 0.9944 0.2-250 0.2 0.05
Metoprolol -81 ± 12 7.64 ± 0.051 84 13 14 5 20 81 ± 11 89 ± 9 100 ± 5 0.9929 2.8-500 2.8 0.9
Nicotine 59 ± 17 6.18 ± 0.032 51 10 8 13 13 73 ± 12 115 ± 23 91 ± 21 0.9859 2.6-250 2.6 0.9
Nadolol -20 ± 10 5.13 ± 0.022 77 5 12 13 12 106 ± 18 99 ± 2 112 ± 10 0.9949 2.2-500 2.2 0.7
Nordiazepam -13 ± 24 11.18 ± 0.016 78 7 13 15 15 95 ± 5 83 ± 9 108 ± 5 0.9972 2.4-250 2.4 0.8
Oxamyl -20 ± 23 6.17 ± 0.001 90 11 14 18 16 124 ± 33 113 ± 25 100 ± 19 0.9956 1.9-500 1.9 0.6
Oxazepam -10 ± 19 10.19 ± 0.012 86 15 12 1 18 81 ± 15 122 ± 14 76 ± 1 0.9948 3.2-250 3.2 1.1
Pirenzipine -41 ± 2 5.33 ± 0.016 74 5 3 7 17 82 ± 7 97 ± 11 119 ± 13 0.9917 0.4-500 0.4 0.1
Prometon -51 ± 11 11.22 ± 0.002 71 5 2 9 7 92 ± 4 104 ± 7 100 ± 9 0.9971 0.9-500 0.9 0.3
Propamocarb -65 ± 8 5.20 ± 0.022 47 3* 8 1 8 64 ± 5 63 ± 5 92 ± 13 0.9934 0.6-500 0.6 0.2
Propazine -43 ± 8 11.85 ± 0.015 70 7 12 6 13 102 ± 9 80 ± 3 93 ± 19 0.9919 3.5-250 3.5 1.2
Propranolol -56 ± 12 9.96 ± 0.015 76 19 15 5 19 74 ± 5 74 ± 10 107 ± 6 0.9990 7.1-250 7.1 2.4
Risperidone -76 ± 4 10.28 ± 0.001 73 1 8 5 15 101 ± 5 104 ± 12 100 ± 1 0.9924 0.4-500 0.4 0.1
Rizatriptan -47 ± 5 4.69 ± 0.021 55 14 14 8 13 101 ± 13 118 ± 6 122 ± 9 0.9955 3-500 3.0 1.0
Salbutamol 7 ± 10 3.30 ± 0.016 26 13 10 15 24 88 ± 16 96 ± 13 117 ± 16 0.9987 7-500 7.0 2.0
Sulfadimethoxine -80 ± 3 4.37 ± 0.016 76 15 7 6 17 87 ± 20 87 ± 6 124 ± 30 0.9986 0.9-500 0.9 0.3
Sulfamethazine -75 ± 3 4.70 ± 0.011 78 6 12 10 23 90 ± 13 76 ± 15 118 ± 12 0.9981 1-500 1.0 2.9
Sulfapyridine -61 ± 7 4.27 ± 0.014 77 6 15 12 17 108 ± 3 92 ± 15 125 ± 3 0.9873 3-500 3.0 1.0
Tacrine -72 ± 4 6.51 ± 0.060 70 5 12 11 15 93 ± 5 104 ± 20 85 ± 10 0.9912 1.6-500 1.6 0.5
Tamsulosin -39 ± 14 9.91 ± 0.001 78 1 15 16 17 72 ± 4 121 ± 12 84 ± 12 0.9976 2.6-500 2.6 0.8
Temazepam -33 ± 12 11.13 ± 0.002 81 9 6 9 13 109 ± 7 88 ± 10 100 ± 9 0.9936 0.5-500 0.5 0.2
Thiacloprid - - 7.09 ± 0.015 100 7 11 3 9 119 ± 9 83 ± 7 117 ± 3 0.9993 0.2-500 0.2 0.07
Timolol -45 ± 3 7.24 ± 0.050 72 15 12 10 16 73 ± 14 98 ± 21 107 ± 10 0.9940 25.2-250 25.2 8.3
Tramadol -67 ± 9 8.53 ± 0.078 91 10 15 12 16 109 ± 12 105 ± 14 82 ± 10 0.9957 3.1-500 3.1 1.0
Trimethoprim -67 ± 5 6.06 ± 0.001 73 20 8 3 16 57 ± 20 92 ± 11 121 ± 15 0.9915 0.1-500 0.1 0.04
Verapamil -67 ± 8 12.03 ± 0.002 67 13 8 8 15 82 ± 10 109 ± 19 117 ± 9 0.9904 2.4-250 2.4 0.8
Warfarin -71 ± 4 6.17 ± 0.012 75 4 14 9 18 74 ± 3 109 ± 16 96 ± 8 0.9959 0.9-500 0.9 0.3
Intra-day Precision (%RSD) Accuracy (%)
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Sampling locations of collected biota and surface water samples within the 
respective river catchments of Suffolk. Black dots indicate urbanised areas.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Comparison of predicted logBCF data from EPI suite and ANN model, for 
individual raw values please see SI Table S5. 
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Figure 3: Heatmap of compounds determined in the biolgoical samples that showed 
acceptable method performance. G, H, A or E indicate the sampled species G. 
pulex, H. pellucidula, A. aquaticus or E. vulgata, respectively. Grey tiles indicate 
compounds that were detected but below the limits of quantification.    
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Figure 4: Heatmap of compounds determined in the surface water samples. All sites 
were samples in triplicate except for Site 10 (n=2). Grey tiles indicate compounds 
that were detected but below the limits of quantification, decimal points indicate site 
replicates.  
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Figure 5: (a) Toxic pressure analysis of measured pesticides quantified by internal 
toxic units (logTU) (b) effect pressure analysis of measured pharmaceuticals and 
illicit drugs quantified by internal effect units (logEU)   
 
(a) 
(b) 
